Literature DB >> 7751395

Molecular epidemiology of Candida isolates from AIDS patients showing different fluconazole resistance profiles.

A Lischewski1, M Ruhnke, I Tennagen, G Schönian, J Morschhäuser, J Hacker.   

Abstract

Thirty Candida isolates obtained from the oropharynxes of three AIDS patients were genotypically characterized. In vitro fluconazole MIC determination revealed increasing fluconazole resistances during treatment, thereby confirming the in vivo situation. Pulsed-field gel electrophoresis karyotyping, randomly amplified polymorphic DNA analysis, and hybridizations with Candida albicans repetitive element 2 were used to determine possible genotypic changes. The isolates from two patients showed genetic homogeneity, suggesting the selection for resistant variants. One patient experienced a strain switch to Candida krusei. Horizontal spread of identical strains between the patients could be excluded. However, the molecular methods used might not be sufficient to detect the underlying genetic basis of resistance to fluconazole.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751395      PMCID: PMC228034          DOI: 10.1128/jcm.33.3.769-771.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Variation in the electrophoretic karyotype analysed by the assignment of DNA probes in Candida albicans.

Authors:  S Iwaguchi; M Homma; K Tanaka
Journal:  J Gen Microbiol       Date:  1990-12

Review 3.  Putative virulence factors of Candida albicans.

Authors:  J E Cutler
Journal:  Annu Rev Microbiol       Date:  1991       Impact factor: 15.500

4.  Chromosomal rearrangements associated with morphological mutants provide a means for genetic variation of Candida albicans.

Authors:  E P Rustchenko-Bulgac; F Sherman; J B Hicks
Journal:  J Bacteriol       Date:  1990-03       Impact factor: 3.490

Review 5.  Molecular mechanisms of drug resistance in fungi.

Authors:  H Vanden Bossche; P Marichal; F C Odds
Journal:  Trends Microbiol       Date:  1994-10       Impact factor: 17.079

Review 6.  Dynamics of the bacterial genome: deletions and integrations as mechanisms of bacterial virulence modulation.

Authors:  M Ott
Journal:  Zentralbl Bakteriol       Date:  1993-06

7.  Isolation, characterization, and sequencing of Candida albicans repetitive element 2.

Authors:  B A Lasker; L S Page; T J Lott; G S Kobayashi
Journal:  Gene       Date:  1992-07-01       Impact factor: 3.688

8.  Electrophoretic karyotypes of clinically isolated yeasts of Candida albicans and C. glabrata.

Authors:  K Asakura; S Iwaguchi; M Homma; T Sukai; K Higashide; K Tanaka
Journal:  J Gen Microbiol       Date:  1991-11

9.  Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation.

Authors:  P J Gallagher; D E Bennett; M C Henman; R J Russell; S R Flint; D B Shanley; D C Coleman
Journal:  J Gen Microbiol       Date:  1992-09

Review 10.  High-frequency phenotypic switching in Candida albicans.

Authors:  D R Soll; B Morrow; T Srikantha
Journal:  Trends Genet       Date:  1993-02       Impact factor: 11.639

View more
  11 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 2.  Evolution of microbial pathogens.

Authors:  J Morschhäuser; G Köhler; W Ziebuhr; G Blum-Oehler; U Dobrindt; J Hacker
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

3.  Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans.

Authors:  C Pujol; S Joly; S R Lockhart; S Noel; M Tibayrenc; D R Soll
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 4.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 5.  Azole resistance in Candida.

Authors:  D W Denning; G G Baily; S V Hood
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

6.  Genotyping and Persistence of Candida albicans from Pregnant Women with Vulvovaginal Candidiasis.

Authors:  Cecilia V Tapia; Germán Hermosilla; Paula Fortes; Claudio Alburquenque; Sergio Bucarey; Hugo Salinas; Paula I Rodas; María Cristina Díaz; Fabien Magne
Journal:  Mycopathologia       Date:  2016-11-23       Impact factor: 2.574

7.  Comparison of four molecular typing methods for evaluating genetic diversity among Candida albicans isolates from human immunodeficiency virus-positive patients with oral candidiasis.

Authors:  T M Díaz-Guerra; J V Martínez-Suárez; F Laguna; J L Rodríguez-Tudela
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

8.  Clonal and spontaneous origins of fluconazole resistance in Candida albicans.

Authors:  J Xu; A R Ramos; R Vilgalys; T G Mitchell
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

Review 9.  Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.

Authors:  K L Goa; L B Barradell
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

10.  Random amplification of polymorphic DNA and microsatellite genotyping of pre- and posttreatment isolates of Candida spp. from human immunodeficiency virus-infected patients on different fluconazole regimens.

Authors:  D Metzgar; A van Belkum; D Field; R Haubrich; C Wills
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.